DN

Dulari Naimish Bhatt

Active Director Director DIN 11842141
DIN 11842141 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Dulari Naimish Bhatt

Dulari Naimish Bhatt is a Director at Drn Research Network Private Limited (since 2026).

DIN 11842141
Primary Designation Director
First Appointment 21 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Drn Research Network Private Limited U58190GJ2026PTC181053
Director21 Jul 20262026Active

Board colleagues of Dulari Naimish Bhatt

NameDINCompanyDesignation
Jalaja Pandya11842140Drn Research Network Private LimitedDirector
Naimish Sanatkumar BhattDrn Research Network Private LimitedIndividual Subscriber

Directorship timeline

Open interactive timeline →
Drn Research Network Private Limited
Premium access

Shareholding and investment profile for Dulari Naimish Bhatt

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dulari Naimish Bhatt

Dulari Naimish Bhatt currently holds 1 directorship: Drn Research Network Private Limited (Director, since 21 Jul 2026).

Dulari Naimish Bhatt was first appointed on 21 Jul 2026 as Director at Drn Research Network Private Limited.

The current boards of Dulari Naimish Bhatt's companies include Jalaja Pandya (Drn Research Network Private Limited), Naimish Sanatkumar Bhatt (Drn Research Network Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available